A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Our easy-to-read patient fact sheet provides clinicians with information on the symptoms of delirium vs dementia and AD.

Dr. Kimberly Doyle from Baylor Scott & White shares valuable tips to ward off cognitive decline and keep your mind sharp as ...

Canine cognitive dysfunction resembles human dementia. Other situations ... which may include dog anxiety medication. Managing anxiety in dogs takes a multi-modal approach with medication and ...

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

Anxiety and depression are significant risk factors for AD, and conversely, AD increases the likelihood of developing these psychiatric conditions. A systematic review of 14,760 studies showed ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.